- Home
- THAR vs VERB Comparison
THAR vs VERB Comparison
Compare THAR & VERB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THAR
- VERB
- Stock Information
- Founded
- THAR 2017
- VERB 2014
- Country
- THAR United States
- VERB United States
- Employees
- THAR N/A
- VERB N/A
- Industry
- THAR Biotechnology: Pharmaceutical Preparations
- VERB Other Consumer Services
- Sector
- THAR Health Care
- VERB Consumer Discretionary
- Exchange
- THAR Nasdaq
- VERB Nasdaq
- Market Cap
- THAR 2.4M
- VERB 5.1M
- IPO Year
- THAR 2022
- VERB N/A
- Fundamental
- Price
- THAR $1.49
- VERB $5.87
- Analyst Decision
- THAR Strong Buy
- VERB Strong Buy
- Analyst Count
- THAR 1
- VERB 1
- Target Price
- THAR $17.00
- VERB $60.00
- AVG Volume (30 Days)
- THAR 197.4K
- VERB 58.1K
- Earning Date
- THAR 05-20-2025
- VERB 05-16-2025
- Dividend Yield
- THAR N/A
- VERB N/A
- EPS Growth
- THAR N/A
- VERB N/A
- EPS
- THAR N/A
- VERB N/A
- Revenue
- THAR N/A
- VERB $895,000.00
- Revenue This Year
- THAR N/A
- VERB $287.49
- Revenue Next Year
- THAR N/A
- VERB $47.06
- P/E Ratio
- THAR N/A
- VERB N/A
- Revenue Growth
- THAR N/A
- VERB 1320.63
- 52 Week Low
- THAR $0.95
- VERB $3.81
- 52 Week High
- THAR $6.45
- VERB $40.40
- Technical
- Relative Strength Index (RSI)
- THAR 54.95
- VERB 63.87
- Support Level
- THAR $1.41
- VERB $5.04
- Resistance Level
- THAR $1.89
- VERB $4.78
- Average True Range (ATR)
- THAR 0.18
- VERB 0.41
- MACD
- THAR 0.04
- VERB 0.15
- Stochastic Oscillator
- THAR 52.38
- VERB 98.35
About THAR Tharimmune Inc.
Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset, known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.
About VERB Verb Technology Company Inc.
Verb Technology Co Inc leader in interactive video-based sales applications, transforms how businesses attract and engage customers. VERB's Software-as-a-Service platform, based on its proprietary interactive video technology, comprises a suite of easy-to-use, subscription-based sales enablement software products. The segments of the company are MARKET.live and Go Fund Yourself, and it derives maximum revenue from MARKET.live segment.